---
figid: PMC6858516__nihms-1054030-f0001
figlink: /pmc/articles/PMC6858516/figure/F1/
number: F1
caption: Genomic alterations are often heterogeneous across patients with metastatic
  castration-resistant prostate cancer (mCRPC). Different alterations can have distinct
  biological roles in driving mCRPC progression and response, and resistance to therapies.
  By understanding each altered gene or pathway in an individual, precision medicine
  has the potential to guide unique therapeutic approaches for patients and improve
  clinical outcomes. A, androgen; AR, androgen receptor; ARm, mutant AR; ARV, AR splice
  variant; CDK, cyclin-dependent kinase; NEPC, neuroendocrine prostate cancer.
pmcid: PMC6858516
papertitle: Towards precision oncology in advanced prostate cancer.
reftext: Sheng-Yu Ku, et al. Nat Rev Urol. ;16(11):645-654.
pmc_ranked_result_index: '19959'
pathway_score: 0.9180719
filename: nihms-1054030-f0001.jpg
figtitle: Towards precision oncology in advanced prostate cancer
year: ''
organisms:
- Mus musculus
- Homo sapiens
ndex: 3f9d0531-df0f-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6858516__nihms-1054030-f0001.html
  '@type': Dataset
  description: Genomic alterations are often heterogeneous across patients with metastatic
    castration-resistant prostate cancer (mCRPC). Different alterations can have distinct
    biological roles in driving mCRPC progression and response, and resistance to
    therapies. By understanding each altered gene or pathway in an individual, precision
    medicine has the potential to guide unique therapeutic approaches for patients
    and improve clinical outcomes. A, androgen; AR, androgen receptor; ARm, mutant
    AR; ARV, AR splice variant; CDK, cyclin-dependent kinase; NEPC, neuroendocrine
    prostate cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - AKT1
  - AKT2
  - AR
  - ARMC9
  - ATM
  - BRCA2
  - CDK12
  - CDK4
  - CDK6
  - CHEK2
  - CCND1
  - CCND2
  - CCND3
  - E2F7
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F8
  - RB1
  - Abiraterone
  - enzalutamide
  - platinum
  - PEN
  - adenocarcinoma
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: ARm
  symbol: ARM
  source: hgnc_alias_symbol
  hgnc_symbol: ARMC9
  entrez: '80210'
- word: ATM
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: BRCA2
  symbol: BRCA2
  source: hgnc_symbol
  hgnc_symbol: BRCA2
  entrez: '675'
- word: CDK12
  symbol: CDK12
  source: hgnc_symbol
  hgnc_symbol: CDK12
  entrez: '51755'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: CHEK2
  symbol: CHEK2
  source: hgnc_symbol
  hgnc_symbol: CHEK2
  entrez: '11200'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: (RB1/TP53)
  symbol: RB1
  source: hgnc_symbol
  hgnc_symbol: RB1
  entrez: '5925'
chemicals:
- word: Abiraterone
  source: MESH
  identifier: C089740
- word: enzalutamide
  source: MESH
  identifier: C540278
- word: platinum
  source: MESH
  identifier: D010984
- word: PEN
  source: MESH
  identifier: C035086
diseases:
- word: adenocarcinoma
  source: MESH
  identifier: D000230
figid_alias: PMC6858516__F1
redirect_from: /figures/PMC6858516__F1
figtype: Figure
---
